title: Heat shock protein 90 (HSP90) inhibition in acute myeloid leukemia--targeting of disease heterogeneity through direct and indirect antileukemic effects.
authors.forename: Øystein
authors.initials: Ø
authors.lastname: Bruserud
authors.forename: Kimberley J
authors.initials: KJ
authors.lastname: Hatfield
authors.forename: Håkon
authors.initials: H
authors.lastname: Reikvam
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000494:pharmacology*; D016227:Benzoquinones / Q000008:administration & dosage*; D018841:HSP90 Heat-Shock Proteins / Q000037:antagonists & inhibitors*; D056572:Histone Deacetylase Inhibitors / Q000008:administration & dosage*; D006801:Humans; D047029:Lactams, Macrocyclic / Q000008:administration & dosage*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*
chemical_list: D016227:Benzoquinones; D018841:HSP90 Heat-Shock Proteins; D056572:Histone Deacetylase Inhibitors; D047029:Lactams, Macrocyclic; C112765:tanespimycin